Chloe Chose

Ms. Chloe Chose

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
TKThomas Leonidas Karadimas
Thomas Leonidas Karadimas
THThien Huong Huynh
Thien Huong Huynh
CCChloe Chose
Chloe Chose
GZGuston Zervoudakis
Guston Zervoudakis
BCBryan Clampitt
Bryan Clampitt
ALAlexander Lazarides
Alexander Lazarides
Primary bone malignancies, including osteosarcoma (OS), are rare but aggressive. Current OS treatment, involving surgical resection and chemotherapy, has improved survival for non-metastatic cases but remains ineffective for recurrent or metastatic OS. Oncolytic viral therapy (OVT) is a promising alternative, using naturally occurring or genetically modified viruses to selectively target and lyse cancer cells and induce a robust immune response against remaining OS cells. Various oncolytic viruses (OVs), such as adenovirus, herpes simplex virus, and measles virus, have demonstrated efficacy in preclinical OS models. Combining OVT with other therapeutics, such as chemotherapy or immunotherapy, may further improve outcomes. Despite these advances, challenges in reliability of preclinical models, safety, delivery, and immune response must be addressed to optimize OVT for clinical use. Future research should focus on refining delivery methods, exploring combination treatments, and clinical trials to ensure OVT’s efficacy and safety for OS. Overall, OVT represents a novel approach with the potential to drastically improve survival outcomes for patients with OS.

1 December 2025 in Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
SSSamantha Schimmel
Samantha Schimmel
CCChloe Chose
Chloe Chose
RRRichard Rivera
Richard Rivera
BCBryan Clampitt
Bryan Clampitt
SSSchahin Salmanian
Schahin Salmanian
PAPuya Alikhani
Puya Alikhani
Background: Adult spinal deformity (ASD) can result in debilitating symptoms and often necessitates surgical intervention. Postoperative complications—including thromboembolic events, proximal junctional kyphosis (PJK), pseudoarthrosis, and rod fracture—are common and can severely impact outcomes. While spinal bracing is commonly employed postoperatively, its’ clinical value remains unproven. The aim of this study was to compare complication rates, pain levels, and outcomes between patients who received thoracolumbosacral orthosis (TLSO) bracing and those who did not following ASD surgery. Methods: We conducted a retrospective review of consecutive ASD surgeries at our tertiary care center between 2016 and 2023. ASD surgery was defined as multilevel fusion involving at least 5 vertebral levels, extending from the pelvis to L2 or above. Surgical approaches included open or minimally invasive methods via different interbodies such as transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), or lateral lumbar interbody fusion (LLIF). Nine surgeons participated in the cohort. Results: Of 265 patients, 193 (73%) received TLSO bracing postoperatively. Braced patients had a significantly increased risk of rhabdomyolysis [odds ratio (OR) =9.959; P<0.001] and deep vein thrombosis (DVT) (OR =5.960; P=0.007). Long-term opioid use (≥12 months) was more common in braced patients (OR =3.895; P=0.002), and they reported higher postoperative back and leg pain (P<0.05). Bracing was not associated with a reduction in surgical complications, nor did it improve spinopelvic alignment outcomes. Conclusions: Routine bracing following ASD surgery does not reduce mechanical or surgical complications and may contribute to immobility-related morbidity and prolonged pain management. Forgoing postoperative bracing may improve patient outcomes and reduce healthcare costs. These findings support a reevaluation of routine bracing in ASD care.

14 June 2025 in World Neurosurgery
Verified
Journal Article
Open access
SSSchahin Salmanian
Schahin Salmanian
SSSamantha Schimmel
Samantha Schimmel
BCBryan Clampitt
Bryan Clampitt
MTMaya Toothman
Maya Toothman
PAPetra Allen
Petra Allen
PKPatrick Kim
Patrick Kim
Spinal stenosis is a common degenerative condition affecting quality of life. Minimally invasive surgical (MIS) techniques like tubular and endoscopic decompression are increasingly favored over open surgery, but direct comparisons remain limited. This study evaluates their relative effectiveness in terms of operative metrics, postoperative pain, complications, and hospital stay. We conducted a retrospective single-center review of 180 patients who underwent tubular (n = 101) or endoscopic (n = 79) MIS decompression for lumbar spinal stenosis between June 2021 and April 2024. Demographics, perioperative variables, and outcomes such as pain scores, infection rates, reoperations, and hospital stay were compared using standard statistical tests. Both groups had similar complication and reoperation rates. Endoscopic patients reported significantly lower immediate postoperative pain (P = 0.001) and greater pain reduction from baseline (P = 0.020). No infections occurred in the endoscopic group, compared to a 5.0% infection rate in the tubular group (P = 0.045). Endoscopic cases also showed shorter in-room to incision times (P = 0.045) and reduced closure durations (P < 0.001). Hospital stay length was comparable (P = 0.138), although complications prolonged stays in the tubular group. Both techniques are effective for MIS spinal decompression. Endoscopic surgery offers advantages in short-term outcomes, including lower infection risk, improved pain relief, and greater procedural efficiency. These findings support its growing role, although further prospective studies are warranted to refine clinical recommendations.

11 June 2025 in Current Oncology Reports
Verified
Journal Article
Closed access
PDF file
CCChloe Chose
Chloe Chose
GZGuston Zervoudakis
Guston Zervoudakis
TKThomas Karadimas
Thomas Karadimas
THThien Huong Huynh
Thien Huong Huynh
SLSean Lapp
Sean Lapp
ALAlexander Lazarides
Alexander Lazarides

18 June 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CCChloe Chose
Chloe Chose
TKThomas Leonidas Karadimas
Thomas Leonidas Karadimas
LHLucy Hederick
Lucy Hederick
AGAnthony Michael Griffin
Anthony Michael Griffin
VJVeena Jajoo
Veena Jajoo
ALAlexander Lazarides
Alexander Lazarides
Background/Objectives: Staged resection with temporizing vacuum-assisted closure (VAC) has been adopted to facilitate margin assessment and local control of soft tissue sarcomas (STS). Accordingly, the objective of this study is to compare rates of local recurrence (LR) among superficial STS patients treated with and without temporizing VAC therapy. Methods: We conducted a multi-institutional retrospective cohort study of superficial STS patients treated at three tertiary care centers. Patients were matched by grade, and descriptive statistics and multivariate binary logistic regression were performed. Results: After matching, 314 superficial STS patients were included in analysis. VAC patients were more likely to present with a history of prior unplanned excision (p = 0.024), with recurrent disease (p = 0.004), harbor a diagnosis of myxofibrosarcoma (p < 0.001), and have positive initial surgical margins (p < 0.001). After multivariate analysis, VAC use remained independently associated with increased LR rates (OR = 4.117; p = 0.003). Conclusions: In this multi-institutional analysis of superficial STS patients, staged resection with temporizing VAC was not associated with improved LR rates. Rather, the VAC cohort represented distinctly higher-risk tumor biology and complex oncologic presentations, in whom the risk of LR may not be fully mitigated by surgical staging alone.

15 July 2026 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
CCCaleb Cummings
Caleb Cummings
JRJoseph Redding
Joseph Redding
CCChloe Chose
Chloe Chose
STSarah C. Tepper
Sarah C. Tepper
DJDavid M. Joyce
David M. Joyce
ALAlexander Lazarides
Alexander Lazarides
Background: Dedifferentiated chondrosarcoma is the most aggressive subtype of chondrosarcoma; however, imaging features that independently distinguish it from other subtypes remain unclear. The purpose of this study was to identify independent imaging predictors of long bone dedifferentiated chondrosarcoma to signal for expedited biopsy and treatment. Methods: This retrospective study incorporated consecutive patients undergoing resection at a tertiary center for primary intramedullary long bone chondrosarcoma between February 2001 and January 2024. Inclusion required preoperative MRI and postoperative pathological confirmation. Seven imaging features were analyzed. Multivariate regression investigated independent predictors of dedifferentiated versus non-dedifferentiated chondrosarcoma. Results: Sixty-seven patients were included. Of these, 23 (34%) patients presented with dedifferentiated chondrosarcoma, while 43 (64%) had conventional chondrosarcoma (21 grade 1, 18 grade 2, 4 grade 3) and one (1.5%) had grade 3 mesenchymal chondrosarcoma. On multivariate analysis, bone marrow edema was the only independent predictor of dedifferentiated status ( p = 0.0091). This association persisted after controlling for age, sex, and tumor size ( p = 0.0057). Bone marrow edema achieved a sensitivity and specificity of 87% and 68%, respectively, and the greatest area under the ROC curve among individual imaging features (AUC = 0.78, p = 0.0027), while the overall combined model achieved even greater discrimination (AUC = 0.87, p < 0.001). Conclusions: Marrow edema was the only imaging feature that independently predicted dedifferentiated chondrosarcoma in multivariable analysis. Although incorporation of additional imaging findings provides the highest overall diagnostic accuracy, marrow edema alone demonstrates high sensitivity and is a readily identifiable marker that may prompt expedited biopsy when identified on routine preoperative MRI.